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AbstrACt
Objective To evaluate diagnostic criteria for idiopathic 
normal pressure hydrocephalus (INPH) among patients 
with memory impairment, and to estimate the incidence 
of INPH.
Design Prospective observational cross- section and 
cohort study of diagnostic accuracy.
setting Memory Disorders Clinic following referral by the 
medical practitioners.
Participants 408 consecutive patients enrolled 2010–
2014.
Outcome measures Reference diagnostic test was the 
clinical judgement of an experienced specialist based 
on the presence of cognitive impairment and/or balance 
and gait disorders in the presence of dilated ventricles. 
Mini- Mental State Examination (MMSE), Tinetti balance 
and gait tests were performed before and 12 months 
after ventriculoperitoneal shunt surgery. The association 
between reference diagnosis, clinical and brain CT scan 
measurements was estimated by multivariate Poisson 
regression. Triage index diagnostic test scores were 
calculated from the regression coefficients, with diagnostic 
thresholds selected using receiver operating characteristic 
analysis.
results The presence of balance and/or gait disorders, 
especially fear of falling, difficulty standing on toes/
heals, urinary disturbances, ventriculomegaly with 
Evans ratio greater than Combined Diagnostic Threshold 
(0.377-{Maximum width of posterior horns*0.0054}), 
strongly predict the diagnosis of INPH; while hallucinations 
and/or delusions and forgetfulness reduce the likelihood 
of the diagnosis. This triage index test had high sensitivity 
(95.2%) and specificity (91.7%). 62 of 408 (15%) 
participants with cognitive impairment had INPH, an 
incidence of 11.9/100 000/year and 120/100 000/year 
over 75 years. 96% of participants following shunting, 
compared with 45% of the non- shunted, improved by over 
25% of available measurable improvement in either MMSE 
or balance/gait scores (51% difference; 95% CI 28% to 
74%; p<0.001), and 56% vs 5% improved by over 50% of 
maximum in both (51% difference; 95% CI 30% to 73%; 
p<0.001).
Conclusion The triage index test score is a simple 
tool that may be useful for physicians to identify INPH 
diagnoses and need for referral for shunt surgery, which 
may improve cognitive, balance and gait functioning.
IntrODuCtIOn
Idiopathic normal pressure hydrocephalus 
(INPH) is one of the few potentially treatable 
causes of dementia. Diagnosis is based on 
the clinical triad of gait disturbance, cogni-
tive decline and urinary incontinence in the 
presence of enlarged ventricles. The condi-
tion is treated by diversion of cerebrospinal 
fluid, most commonly by the insertion of a 
ventriculoperitoneal (V- P) shunt.1–4 INPH 
generally occurs in older people.5 6 However, 
diagnosis is difficult since the symptoms 
and ventriculomegaly could be attributed 
to other neurodegenerative diseases.4 More-
over, no definitive method exists to confirm 
the diagnosis, and the only validation of the 
diagnosis is improvement following shunt 
surgery. Guidelines for INPH diagnosis have 
strengths and limitations of this study
 ► This study has developed a triage index test that
might be applied by non- specialist practitioners to
select patients with a preliminary the diagnosis of id-
iopathic normal pressure hydrocephalus (INPH) who
might be suitable for specialist INPH management.
 ► This is a prospective study within a define popula-
tion and well- established clinical service with de-
tailed clinical and radiological assessments that is
likely to identify the majority of patients with INPH.
 ► Internal validation supported the triage index test
values.
 ► This preliminary study requires external validation in 
different and larger populations.
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been recommended including Evans ratio >0.33 and the 
disproportionately enlarged subarachnoid space hydro-
cephalus (DESH) criteria,7 but these guidelines are 
mainly used in tertiary referral centres, and it is left to the 
skills of experienced specialists to make the diagnosis and 
recommend treatment. However, there is still wide varia-
tion in the diagnostic criteria, which may lead to misdiag-
nosis as other forms of dementia.8 Thus, there have been 
few reliable estimates of the incidence of INPH, which 
has led to it being viewed as a rare condition.4 8 9 There is 
also a need for a triage screening test that is simple and 
accurate enough to be used by the general practitioners 
in routine practice.
The aims of this study are to: (1) estimate the incidence 
of INPH among patients with memory impairment; (2) 
describe the diagnostic features of patients diagnosed 
with INPH using the Launceston reference criteria, by 
comparing the clinical and radiological features of INPH 
with non- INPH patients; (3) create triage index tests 
before and after brain CT scan; (4) estimate their diag-
nostic accuracy against the reference (specialist) diag-
nosis and (5) test the validity of the reference diagnostic 
criteria by estimating the change in cognitive, balance 
and gait functioning following V- P shunting.
MethODs
 study design and setting
This was a prospective observational cross- sectional and 
cohort study. Consecutive patients with memory impair-
ment referred by general practitioners between April 
2010 and July 2013 to the Launceston Memory Disorders 
Clinic, the only such clinic in Northern Tasmania, were 
recruited. A Standards for Reporting Diagnostic accuracy 
studies (STARD) flow diagram of participant numbers for 
the overall study is shown in online supplementary mate-
rials, figure 1S.
 Patient and public involvement statement
While there was no formal involvement of patients or 
their representatives in the planning, design and perfor-
mance of this research, prior to this study, the specialist 
(GR) had been contacted by the patients and their rela-
tives from other Australian states with memory problems 
seeking consultations and treatments following publicity 
arising from previous research publication. Those 
patients had been unable to access suitable specialists 
willing and able to undertake the appropriate investiga-
tions locally. Part of the motivation for this research was 
to assist those services to become familiar and comfort-
able with delivering the appropriate investigations and 
treatments desired by patients. Regular meetings with the 
participants were held to inform them of the progress 
and results of this study.
 Data collection
All participants underwent standard clinic assessment, 
and the reference diagnosis was made by the same 
specialist physician/geriatrician (GR).10 Data included 
detailed history of memory, balance, gait and urinary 
symptoms including features suggesting dementia such 
as aphasia, agnosia, apraxia, hallucination, delusion, 
agitation, aggressive behaviour and change in personality. 
Examination included cognitive function using the Mini- 
Mental State Examination (MMSE),11 and balance and 
gait functions by standing with eyes closed and on toes 
and heels, and the tandem walk test (walking 2 m heel to 
toe). All patients had a brain CT scan, and an additional 
MRI for suspected INPH patients.
The diagnosis of non- INPH dementia was made 
according to the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition, and the diagnosis of 
Alzheimer’s disease (AD), vascular and mixed dementia, 
frontal lobe dementia, Lewy body dementia, and Parkin-
son’s disease dementia, were made according to standard 
criteria.12 Mild cognitive impairment was diagnosed using 
the Petersen criteria.13
Definition of diagnostic reference standard
INPH was diagnosed by the specialist physician (GR) 
using his routine practice. This was based on fulfilling 
three criteria: (1) cognitive impairment (not necessarily 
dementia), and balance and gait disorder; (2) dilated 
ventricles, (regardless of cerebral atrophy and white 
matter ischaemia) and (3) no evidence of an antecedent 
event such as head trauma, meningitis, intracerebral 
haemorrhage or other medical conditions sufficient to 
explain the presenting symptoms. Symptoms and signs 
of Parkinsonism and absence of balance/gait problems 
reduced the suspicion of INPH and reduce the likelihood 
for V- P shunting.
In addition to the routine clinical practice observa-
tions, additional historical, symptomatic, examination 
and radiological observations were made by the specialist 
and study coordinator (as described in study protocol 
in online supplementary materials). These observations 
were used after the end of the study to calculate the triage 
index test scores: the specialist was aware of some of these 
observations at the time he made the reference standard 
diagnosis but was not aware of the final index test scores.
To validate INPH diagnoses, the response to V- P 
shunting was measured. Participants with INPH under-
went assessment by an independent observer at baseline, 
and followed up at 3, 6 and 12 months. The primary effi-
cacy measure was the Clinician’s Interview Based Impres-
sion of Change Plus Caregiver Interview (CIBIC- plus)14: 
evaluating global, cognitive, balance, gait and urinary 
functioning with 7- point scale (+3, markedly improved 
relative to baseline; −3 markedly worse). Secondary effi-
cacy measures included the MMSE for the assessment of 
cognition, and Tinetti balance and gait tests15 for assess-
ment of mobility.
Participants were informed about the study at the 
time of diagnosis. The intention was to treat all INPH 
participants with a V- P shunt. Participants who agreed to 
consider surgery were referred to a single neurosurgical 
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Figure 1 Example of axial brain CT scan showing Evans 
ratio (the maximum bifrontal distance) (1) divided by the 
maximum inner diameter of the skull (2) and the maximum 
width of the posterior horn (3).
department in Hobart, southern Tasmania, which made 
the final decisions about shunt surgery. Patients who did 
not have surgery were used as comparators.
Definition of index test
Two simplified screening tools for potential use by non- 
specialised practitioners (triage tests) to select partici-
pants for brain CT scan and then referral to specialists 
for further evaluation and treatment were constructed by 
estimating the association between the presence of INPH 
and clinical and radiological findings using multivariate 
regression analysis. Brain CT scan of 60 participants with 
non- INPH were randomly selected using the random- 
number generator function in Microsoft Excel. The 
detailed CT scan measurements were performed after 
completion of the study for comparison with the refer-
ence standard and were not used as criteria for the initial 
diagnosis and indication for referral for shunt surgery. 
Selection of the variables to be included in the index test 
predictor models was driven by the automated processes 
of the stepwise regression facility in the Stata statistical 
package, and before the diagnostic accuracy tests for the 
index tests were applied.
Sample size
Sixty participants with INPH and 400 participants overall 
were required to detect a mean 3- point improvement 
in MMSE score in the shunted participants compared 
with zero change in those not shunted (assuming an 
SD of change of 4; alpha 0.05; power 80%; 50% patients 
shunted).
 statistical analysis
The incidence of new diagnoses of INPH in the Memory 
Clinic population was estimated in the Northern Tasmania 
population (Australian Bureau of Statistics, Census 2011), 
with direct age–gender standardisation to the equivalent 
Australian population.
The clinical and radiological observations recorded at 
initial diagnosis in participants with and without an INPH 
were compared in order to construct a triage index test 
for INPH diagnosis. A multivariate Poisson regression 
model was used to estimate the association between the 
INPH diagnosis and an optimum combination of clin-
ical and CT scan features. The predictor variables were 
selected using backward stepwise regression from a list 
included in table 1S of online supplementary materials 
table 1S. From the CT scan, several measurements were 
obtained including Evans ratio (the maximum bifrontal 
distance divided by the maximum inner diameter of the 
skull at the same level in transverse views of the brain) 
(figure 1),16 maximum width of anterior and posterior 
horns; cerebral atrophy and periventricular white matter 
ischaemia.17 The association between Evans ratio and 
maximum width of posterior horns (MWPH) was exam-
ined graphically, and a method was identified for a patient- 
specific modified Evans ratio threshold (Combined 
Diagnostic Threshold, CDT). A total of 233 (3.0%) 
missing observations occurred in a total of 7752 required 
cognitive and urinary observations. No missing observa-
tions occurred in the balance/gait and CT scan domains. 
A total of 377 (92.4%) of 408 patients had complete 
data recorded. Missing data were substituted by multiple 
imputation using the variables in online supplementary 
materials table 1S. The regression coefficients from the 
optimum Poisson regression models were then used to 
calculated risk scores for each patient based on a linear 
additive combination of variables. Two risk scores were 
calculated from the Poisson regression analysis before 
and after CT scan results. The risk scores were examined 
using receiver operating characteristic (ROC) analysis to 
identify a threshold (the index test) with approximately 
95% sensitivity, with estimation of ROC specificity and 
area for those tests. (See online supplementary appendix 
1: Additional Description of Statistical Methodology in 
online supplementary materials for detailed description 
of the study analysis, including internal validation of the 
proposed risk scores using multiple bootstrap sampling. 
This appendix includes online supplementary tables 
2S–9S showing intermediate supporting results of the 
analysis).
The association between the Evans ratio and the cere-
bral atrophy score was estimated using ordered logistic 
regression. The compliance of each INPH patient with 
the International Guideline criteria was determined in 
four domains (cognitive, balance/gait, urinary, imaging), 
and the agreement between the International Guidelines 
diagnosis and the reference diagnostic criteria was tested 
by the inter- rater agreement kappa statistic. The change 
in cognitive, balance/gait, and CIBIC- plus scores were 
compared in participants with or without V- P shunt in the 
first year following diagnosis, using repeated measures 
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Table 1 Diagnoses and demographic characteristics of study participants
Diagnosis (Dx) N % of 408
Age Gender MMSE
Median (IQR) Male % of Dx Median (IQR)
Idiopathic normal pressure hydrocephalus  62 15.2 77.6 (71.3–85.0) 39 62.9 24 (20–27)
Mild cognitive impairment  182 44.6 71.8 (63.5–78.3) 74 40.7 28 (26–29)
Alzheimer's disease  91 22.3 79.9 (73.4–83.6) 39 42.9 21 (17–23)
Mixed dementia  24 5.9 81.4 (77.1–83.2) 13 54.2 20 (15–22)
Vascular dementia  11 2.7 80.0 (65.2–87.4) 7 63.6 18 (15–23)
Frontal lobe dementia  4 1.0 63.9 (52.5–76.2) 3 75.0 24 (20–29)
Lewy body dementia  2 0.5 85.9 (85.5–86.4) 1 50.0 4 (2–6)
Parkinson’s disease dementia  9 2.2 78.4 (78.0–87.6) 3 33.3 17 (14–20)
Other dementia syndromes  23 5.6 67.9 (59.1–78.1) 13 56.5 18 (11–26)
Total  408 76.6 (67.4–82.1) 192 47.1 25 (20–28)
MMSE, Mini- Mental State Examination.
mixed effects linear regression, adjusted for initial scores 
at diagnosis.
The protocol for this study is included at the end of the 
online supplementary material.
All analyses were performed using Stata/MP2 V.14.2 
(StataCorp).
results
 baseline characteristics and diagnoses of patients
A total of 408 consecutive participants with memory 
impairment were enrolled, of whom 215 (53%) were 
women. Their median age was 76.6 years (range 32.6–94.8 
years). Table 1 shows the diagnoses and demographic 
characteristics of the participants. Median duration of 
symptoms was 24 months (IQR 12–42 for INPH; 18–54 for 
non- INPH participants). Sixty- two (15.2%; 95% CIs 11.9% 
to 19.1%) participants had INPH. The flow diagram of 
the participants is shown in online supplementary mate-
rials figure 1S.
 the incidence of InPh
A total of 376 participants were from Northern Tasmania 
(2011 census population of 137 560), 29 were from North-
western Tasmania, and 3 were from Southern Tasmania. 
Fifty- four Northern Tasmanian INPH participants over 
3.3 years (time between first and last recruitment) repre-
sent a minimum incidence of new diagnosis of INPH of 
at least 11.9/100 000/year (95% CI 9.0 to 14.8; age–sex 
standardised 10.1; 95% CI 7.4 to 13.5) (online supple-
mentary table 10S). The raw incidence increased with 
age, with the highest incidence of 120/100 000/year in 
those 75–95 years old.
 Clinical characteristics of participants
The frequency of different complaints, signs and CT 
scan results is shown in online supplementary table 1S. 
For individual features, there was considerable overlap 
between INPH and non- INPH participants, and a high 
degree of cross- correlation between the presence of 
different variables. Fifty- nine of 62 participants with an 
initial diagnosis of INPH had cognitive and balance defi-
cits, with ventriculomegaly on CT scan. Five of the 60 
randomly selected participants with an initial diagnosis of 
non- INPH had cognitive and balance deficits with ventric-
ulomegaly, three of whom had Parkinsonism and two had 
AD combined with INPH. These participants were not 
considered for V- P shunting. Moreover, six participants 
had ventriculomegaly, but were not considered to have 
INPH by both the reference and index test criteria. The 
reasons for accepting or rejecting a diagnosis of INPH 
in 62 INPH participants and a randomly selected sample 
of 60 of 346 non- INPH participants are shown in online 
supplementary table 11S.
Two index tests were constructed to reproduce the diag-
nosis of INPH made by the specialist, before and after a 
CT scan, based on multivariate Poisson regression anal-
ysis. Prior to the CT scan, the presence of balance/gait 
problems, failure of both stand- on- toes and stand- on- heels 
tests, a fear of falling, presence of urinary disturbance 
(all of urinary urgency, nocturnal frequency and inconti-
nence) were the main predictors of INPH (table 2). Being 
more forgetful (Forgetful score  ≥ 3; =immediate recall
score on MMSE <2 (scoring 1=1, 0=2)+forgets names+for-
gets appointments+forgets recent conversations), and the 
presence of delusions/hallucinations were mildly nega-
tively associated with INPH. When the individual predic-
tors were combined into a risk score, the overlap between 
the INPH and non- INPH patients was reduced compared 
with any individual variable. ROC analysis identified a 
threshold for the risk score of −2.25, which identified 59 
of 62 cases of INPH (sensitivity 95.2%), while excluding 
221 of 346 non- INPH cases (specificity of 64.7%). Internal 
validation of the risk scores demonstrated that there was 
only a minor ‘optimism’ bias in the risk score prior to CT 
scans generated directly from the study data, compared 
with that generated from the coefficients derived from 
5Razay G, et al. BMJ Open 2019;9:e028103. doi:10.1136/bmjopen-2018-028103
Open access
Table 2 Association between the presence of idiopathic normal pressure hydrocephalus (INPH) and its clinical predictors 
before CT scans
Poisson regression model
NPH absent NPH present
Coefficient*† IRR* (95% CI) P value(n=346) (n=62)
Constant −4.236 1.00
Clinical judgement of presence of 
balance/gait problems
152 (43.9%) 60 (96.8%) 2.088 (14) 8.07 (2.04 to 32.0) 0.003
Failed both stand- on- toes and stand- on- 
heels tests
132 (38.2%) 56 (90.3%) 1.020 (7) 2.77 (1.32 to 5.82) 0.007
Fear of falling 0 (0.00%) 23 (37.1%) 1.310 (9) 3.71 (2.61 to 5.26) <0.0001
Urinary problems (all of urgency, nocturnal 
frequency, incontinence)
53 (15.3%) 37 (59.7%) 0.744 (5) 2.10 (1.45 to 3.06) <0.0001
Forgetful ≥3‡ 310 (89.6%) 51 (82.3%) −0.692 (−5) 0.50 (0.30 to 0.83) 0.007
Delusions and/or hallucinations 65 (18.8%) 8 (12.9%) −0.307 (−2) 0.74 (0.42 to 1.28) 0.28
Evaluation of diagnostic utility of the risk score derived from the above 
model
 Risk scores (mean (SD)) (range −5.23 to 
0.93)
−3.49 (1.47) −0.97 (1.02) ROC area§ 0.919 (0.881 to 0.957) <0.0001
 Cases with INPH, above diagnostic threshold of −2.25 59 of 62
 Cases without INPH, below diagnostic threshold of 
−2.25
224 of 346
 Sensitivity 95.2% (86.5% to 
99.0%)
 Specificity 64.7% (59.5% to 
69.8%)
*Association between diagnosis of INPH and predictor variables, estimated using stepwise multivariate Poisson regression (IRR; 95% CIs; p
value) with included variables selected from a list including (on history or examination): balance/gait problems, all urinary problems present
(urgency, frequency, incontinence), age, gender, MMSE, agnosia, apraxia, failed gait/balance tests (1) stand- eyes- closed, (2) stand- on- 
toes and stand- on- heels, (3) walk 2 m straight, (4) brisk reflexes present, (5) rigidity, (6) bradykinesia, (7) fear- of- falling, agitation, delusions,
hallucinations, reading problems, expressive aphasia, personality change, forgets recent conversations, appointments, or names, MMSE
immediate recall <2. Missing data were substituted by multiple imputation.
†Risk scores were calculated from the regression coefficients using equation 1; either the raw coefficient, or an integer rounding of 
(coefficient/0.15) (in brackets). The sensitivity and specificity performance of the raw coefficient risk score and the integer rounding risk score 
was identical.
‡Forgetful: presence of 3 or 4 of (1) immediate recall score on MMSE <2; (2) forgets names; (3) forgets appointments and (4) forgets recent 
conversations.
§ROC analysis was used to evaluate and select diagnostic thresholds for the risk scores.
IRR, incidence rate ratio; MMSE, Mini- Mental State Examination; ROC, receiver operating characteristic.
the bootstrap sampling validation process (specificity of 
62.1%). No differences were seen following the CT scans 
in the specificity (91.7%) or the identity of the patients 
chosen between the initial and validation risk scores.
Evans ratio and MWPH were most strongly associ-
ated with the reference diagnosis of INPH. Figure 2 
shows the relationship between CT scan Evans ratio and 
MWPH. Ventriculomegaly, defined as an Evans ratio 
above a patient- specific CDT (with a formula (0.377-
{MWPH*0.0054})), was found by itself to identify 60 of 
62 INPH participants (sensitivity 96.7, 95% CI 88.7 to 
99.6%) and excluded 49 of 60 non- INPH participants 
(specificity 81.7 (95% CI 69.6 to 90.5%). The example 
CT scan shown in figure 1 has an Evans ratio of 0.35 and 
MWPH of 20.1 mm: thus, the patient has a CDT of 0.268 
(0.377-{20.1*0.0054}), and the Evans ratio is well above 
that threshold. In this study, the CDT appeared superior 
to alternative definitions of ventriculomegaly: a threshold 
for Evans ratio ≥0.275 with 96.7% sensitivity had a spec-
ificity of 76.7%; a threshold of ≥0.30 had a sensitivity of 
77.4% and a specificity of 85.0%.
Moreover, cerebral atrophy grade was associated with 
increasing Evans ratio in non- INPH participants (OR 
2.05; 95% CI 1.20 to 3.53; p=0.009), but not in INPH 
participants (OR 0.83; 95% CI 0.51 to 1.35; p=0.46).
When the results of the brain CT scan were included in 
the multivariate analysis (table 3), the diagnosis of INPH 
was predicted by the presence of balance and/or gait 
problems, fear of falling, urinary disturbance and ventric-
ulomegaly (Evans ratio >CDT); while hallucinations and/
or delusions were negatively predictive. Individual vari-
ables were not strongly predictive, but a threshold value 
of −1.0 for the post- CT index test showed a sensitivity of 
95.2% (95% CI 86.5% to 99.0%), and a specificity of 91.7% 
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Figure 2 Relationship between Evans ratio and the maximum width of the posterior horn of the lateral ventricles on CT scan in 
122 study participants diagnosed as INPH or non- INPH at initial assessment. INPH, idiopathic normal pressure hydrocephalus; 
MWPH, maximum width of posterior horns.
(95% CI 81.6% to 97.2%). If the patients with combined 
INPH and Alzheimer’s or Parkinsonism were counted as 
INPH, sensitivity (95.5%) and specificity (98.2%) of the 
index test were increased.
Simplified score sheets (figure 3) for predicting a diag-
nosis of INPH were developed from coefficients of the 
Poisson regression models in tables 2 and 3 (by rounding 
of (coefficient/0.15)). Participants with memory prob-
lems and a total simplified score ≥14 require a brain CT 
scan (sensitivity 95.2, 95% CI 86.3 to 99.0% and specificity 
63.3%, 95% CI 58.0% to 68.4%). After measurements of 
Evans ratio and MWPH, a total score ≥18 suggested the 
need for referral to neurosurgeons for consideration of 
V- P shunting. The simplified risk scores before and after
CT scan had an identical performance to the precise
risk scores, including and excluding the same partici-
pants (sensitivity 95.2 and specificity 91.7, 95% CI 81.6 to
97.2%). The value of the individual participant scores is
shown in online supplementary table 12S. Comparison of
the clinical and CT scan components of the reference test
criteria and International Guidelines is shown in online
supplementary tables 13S, 14S. There was agreement in
98.4% of cognitive, 87.1% of balance and gait, 95.2% of
urinary and 74.2% of CT scan assessments. In 54 (87.1%)
of the patients, there was an agreement between the refer-
ence test criteria and International Guidelines for the
diagnosis of probable INPH, and seven patients fulfilled
the reference test criteria and International Guidelines
for the diagnosis of possible INPH.
Follow- up of participants over 12 months occurred 
to validate the diagnoses of INPH. All were considered 
for V- P shunting, of whom 29 (47%) had a shunt and 
33 participants were not shunted (table 4 shows the 
reason for not shunting). Follow- up of participants was 
less complete in the non- shunted group due to difficulty 
and unwillingness to attend and comply with assessments. 
Thus, 25 shunted and 21 non- shunted participants were 
examined at initial assessments, and at either 6 and/or 
12- month visits.
Participants who were shunted, compared with the
non- shunted, had significantly higher initial MMSE 
scores (25.7 vs 19.8; mean difference 6.0; 95% CI 3.2 to 
8.7; p<0.001), and similar initial Tinetti balance and gait 
scores (14.5 vs 13.9; mean difference 0.6; 95% CI −2.3 to 
3.5; p=0.68). In the shunted group, the mean MMSE score 
improved significantly by about 72% of the maximum 
available improvement (4.75 at 12 months of a possible 
6.1 (ie, 30–23.9)), with the greatest improvement being 
at 12 months. The mean Tinetti scores improved by about 
85% for balance and gait scores (90% for balance and 
78% for gait) with maximum improvement at 6 months 
(table 5). Moreover, subjective assessments using the 
CIBIC- plus rating indicated that participants following 
shunting were very much improved on global, cognitive, 
balance and gait and moderately improved on urinary 
functioning (table 6). There was no association between 
the proportional change in cognitive (OR 0.96; 95% CI 
0.60 to 1.52; p=0.87), balance and gait function (OR 0.93; 
95% CI 0.32 to 2.68; p=0.90) and the index test scores 
derived from the clinical and CT scan assessments.
The proportional change in MMSE and Tinetti balance/
gait scores in the shunted and non- shunted participants at 
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Table 3 Association between the presence of idiopathic normal pressure hydrocephalus (INPH) and its clinical and CT scan 
predictors
Poisson regression model
NPH absent NPH present
(n=60)* (n=62) Coefficient IRR† (95% CI) P value
Constant −3.798
Ventriculomegaly: Evans ratio > (0.377-
{MWPH*0·0054})
11 (18.3%) 60 (96.7%) 2.450 (16) 11.6 (3.04 to 44.1) 0.0004
Clinical judgement of presence of balance/
gait problems
25 (41.7%) 60 (96.7%) 1.267 (8) 3.55 (0.93 to 13.6) 0.064
Fear of falling 0 (0.00%) 23 (37.1%) 0.159 (1) 1.17 (1.02 to 1.35) 0.024
 Urinary problems (all of urgency, nocturnal 
frequency, incontinence)
7 (11.7%) 37 (59.7%) 0.199 (1) 1.22 (1.02 to 1.45) 0.014
Forgetful ≥3‡ 53 (88.3%) 51 (82.3%) −0.203 (−1) 0.82 (0.64 to 1.04) 0.11
Delusions and/or hallucinations 12 (20.0%) 8 (12.9%) −0.136 (−1) 0.87 (0.68 to 1.13) 0.30
 Evaluation of diagnostic utility of the risk score derived from the above model
 Risk scores‡ (mean (SD)) (range −4.14 to 
0.28)
−3.00 (1.15)  −0.21 (0.62) ROC area‡ 0.978 (0.955 to 0.999) <0.0001
 Cases with NPH above diagnostic threshold of −1.0 59 of 62
 Cases without NPH below diagnostic threshold of −1.0 55 of 60
 Sensitivity 95.2% (86.5% to 
99.0%)
 Specificity 91.7% (81.6% to 
97.2%)
*A sample of 60 participants was selected randomly from the 346 non- INPH participants.
†The variables for inclusion in the multivariate model were selected by backward stepwise Poisson regression from a list including (on history 
or examination) balance/gait problems, all urinary problems present (urgency, frequency, incontinence), age, gender, MMSE, agnosia, apraxia, 
failed gait/balance tests 1 (stand- eyes- closed), 2 and 3 (stand- on- toes and stand- on- heels), 4 (walk 2 m straight), 5 (brisk reflexes present), 
6 (rigidity), 7 (bradykinesia), 8 (fear- of- falling), agitation, delusions, reading problems, expressive aphasia, personality change, forgets recent 
conversations, appointments, or names, immediate recall <2, hallucinations, (on CT scan) severe atrophy, severe leucoaraiosis, enlarged 
temporal horns, space- occupying lesion, dilated Silvian fissure, temporal lobe thickening, ventriculomegaly defined as Evans ratio > (3·77-
{MWPH*0·0054}), width between caudate nuclei at the foramen of Munro, maximum width of third ventricle, and minimum width of both cella 
media, maximum width of anterior horns, MWPH. Missing data were substituted by multiple imputation.
‡Risk scores were calculated from the regression coefficients using equation 1; either the raw coefficient, or an integer rounding of 
coefficient/0.15 (in brackets). The sensitivity and specificity performance of the raw coefficient risk score and the integer rounding risk score 
was identical.
IRR, incidence rate ratio; MMSE, Mini- Mental State Examination; MWPH, maximum width of posterior horns; ROC, receiver operating 
characteristic.
follow- up visits is shown in figure 4. The majority of partic-
ipants with available follow- up data who were shunted 
(24 of 25 (96%); vs 9 of 21 non- shunted patients (45%)) 
improved by at least 25% of the available measurable 
improvement in either MMSE or balance/gait scores 
compared with the non- shunted participants (improve-
ment difference 51%; 95% CI 28% to 74%; p<0.001), and 
the majority of participants improved by at least 50% of 
maximum in both MMSE and balance/gait scores (14 of 
25 (56%) shunted vs 1 of 21 (5%) non- shunted; improve-
ment difference 51%; 95% CI 30% to 73%; p<0.001). 
The Launceston reference criteria and International 
Guidelines criteria showed similar response to shunting, 
although only three of the participants who were positive 
for only the Launceston criteria were shunted.
DIsCussIOn
 Key findings
This study demonstrates a triage index test that predicts 
the diagnosis and incidence of INPH among patients with 
memory impairment. The presence of balance and/or gait 
disorders with difficulty standing on toes and heals, fear of 
falling; urinary urgency, nocturnal frequency and inconti-
nence; ventriculomegaly with Evans ratio above CDT (0.377-
{MWPH*0.0054}), strongly predict the diagnosis of INPH, 
while hallucinations and/or delusions; and forgetfulness, 
reduce the likelihood of the diagnosis (seven- item check 
list, figure 3). The study also confirms that V- P shunting is 
associated with improvements in cognitive, balance, gait 
and urinary functioning of patients with INPH in the first 
year; there was no indication of lesser improvements in 
patients with less intensity of symptoms.
The study also suggests INPH is more common in our 
population than has been previously reported. At least 
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Figure 3 Clinical scoring sheet: a simplified risk scoring system to be applied in patients presenting with cognitive problems 
to determine whether a brain CT scan and subsequently a referral to a neurosurgeon are necessary. MMSE, Mini- Mental State 
Examination; MWPH, maximum width of posterior horns.
Table 4 Reasons for not performing V- P shunting
Reasons
Medically unfit for surgery 9
Patient or family’s refusal 12
Intervening comorbidities (metastatic 
cancer n=2, stroke n=1, bowel 
infarction n=1)
4
Presence of parkinsonism 2
Achondroplasia 1
No available consent 1
Waiting for symptoms to deteriorate 
sufficiently
1
Left Tasmania or lost to follow- up 2
Withdrawn from study 1
V- P, ventriculoperitoneal.
15% of patients seen in our memory disorders clinic may 
have INPH.
 Comparison with other studies
 The incidence of INPH
Studies of INPH report an incidence of 1.2–5.5/100 000/
year,4–6 18 with shunt surgery about 1/100 000/year.4 19 
INPH is stated to be a rare cause of dementia.8 A meta- 
analysis of 39 studies between 1987 and 2001 reported 
INPH in 1% of dementia patients.8 We found INPH more 
common, with an incidence of 11.9/100 000/year with 
the rate increasing with age. The true incidence of INPH 
is probably higher as some patients may not have cogni-
tive impairment,6 20 or asymptomatic with ventricular 
enlargement at the time of assessment.20 21
The differences in the reported incidence of INPH may 
be due to selection and ascertainment biases, and retro-
spectivity causing non- detection of some less florid cases; 
having different age groups; and using inconsistence 
diagnostic and inclusion criteria. Thus, INPH is probably 
misdiagnosed, underdiagnosed and undertreated.19 22 
However, it is possible that there are true variations in 
incidence rates in different populations.
 The diagnostic criteria
There is no consensus on common criteria to diagnose 
INPH and predict beneficial response to shunt surgery. 
Various scales and guidelines have been recommended to 
facilitate a more accurate diagnosis, and to select appro-
priate patients who might benefit from shunt surgery.3 7 23 
They are still not widely used: of 15 studies conducted 
following publication of the guidelines, only six followed 
the recommended guidelines,20 possibly due to their lack 
of clarity about how to combine the different symptoms, 
signs and brain imaging. Thus, the skill and experience of 
a specialist remains the reference test for INPH diagnosis.
Our triage index test score, a short seven- item check 
list (figure 3), could be used to select patients with cogni-
tive impairment with a presumptive diagnosis of INPH for 
neurosurgical evaluation and treatment. The criteria were 
efficient at discriminating INPH from non- INPH patients 
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Table 5 Change in objective cognitive and balance/gait scores over the 12 months following initial assessment in shunted 
and non- shunted participants
Non- shunted Shunted
Comparison: shunted versus 
non- shunted patients
N Mean SD N Mean SD Difference* (95% CI) P value
Mini- Mental State Examination (MMSE) score
 Initial 21 22.6 5.6 25 23.4 4.5 0.00
 0–3 months 11 24.2 5.3 14 25.5 3.6 0.48 (−2.51 to 2.51) 0.65
 3–9 months 21 22.2 6.1 24 26.4 3.8 3.35 (0.98 to 5.72) 0.006
 9–16 months 16 22.3 5.9 15 27.8 3.2 4.75 (0.93 to 8.57) 0.015
Tinetti† Balance and Gait score
 Initial 21 13.9 7.1 25 14.5 7.5 0.00
 0–3 months 11 14.6 7.9 14 21.7 3.7 6.54 (1.66 to 11.4) 0.009
 3–9 months 21 14.1 8.3 24 21.8 4.5 7.09 (3.43 to 10.8) <0.001
 9–16 months 16 15.4 7.6 15 19.5 9.5 3.53 (−0.42 to 7.47) 0.080
Tinetti† Balance score
 Initial 21 8.0 4.0 25 8.4 4.2 0.00
 0–3 months 11 8.7 4.8 14 12.8 2.4 3.62 (0.78 to 6.46) 0.013
 3–9 months 21 7.8 4.7 24 12.9 2.5 4.69 (2.54 to 6.84) <0.001
 9–16 months 16 8.2 4.4 15 11.4 5.6 5.35 (0.51 to 5.12) 0.017
Tinetti† Gait score
 Initial 21 5.9 3.2 25 6.1 3.4 0.00
 0–3 months 11 5.9 3.8 14 9.0 1.5 2.87 (0.62 to 5.12) 0.013
 3–9 months 21 6.3 3.7 24 9.0 2.1 2.42 (0.73 to 4.10) 0.005
 9–16 months 16 7.2 3.4 15 8.2 3.9 0.71 (−1.11 to 2.52) 0.45
*Mean difference in scores between shunted and non- shunted participants, estimated using repeated measures mixed effects linear
regression adjusted for initial MMSE score and Tinetti scores (respectively), with the time from initial assessment of the follow- up observations
being treated as a random variable.
†Tinetti Balance and Gait scores have 17- point (0–16) and 13- point (0–12) scales, respectively, with the combined scale being an addition of 
the two scales.
when including clinical and radiological variables. These 
index test diagnostic criteria are consistent with, although 
not precisely coincident with, the ‘probable INPH’ cate-
gory as suggested by the International Guidelines criteria 
for INPH, and they are more precise than the ‘possible 
INPH’ category,3 which would include a number of 
patients not diagnosed with INPH in this study. Ventric-
ulomegaly including larger posterior horns is prevalent 
in INPH, possibly corresponding to smaller callosal angle 
measured at level of posterior commissure that has been 
used for INPH evaluation,24 although posterior cerebral 
atrophy from neurodegenerative disease such as Alzhei-
mer’s disease may confound this significance. DESH is a 
set imaging findings of ventriculomegaly,7 high convexity 
and medial subarachnoid space effacement, and enlarge-
ment of sylvian fissures that has been used for selecting 
patients in the Study of Idiopathic Normal Pressure Hydro-
cephalus on Neurological Improvement (SINPHONI and 
SINPHONI-2) trials,25 26 although it should be noted that 
some INPH shunt- responsive patients do not have DESH, 
and not all patients who had DESH respond to shunting, 
so DESH is not necessary nor sufficient for the diagnosis 
of INPH. However, we did not have these measured at the 
time of examination to enable us to incorporate them in 
triage index test. We hope we can look at these in future 
studies.
There is high degree of overlap between individual 
symptoms and signs of INPH and non- INPH, which 
might lead to misdiagnoses of INPH as other neurode-
generative disorders including AD, Parkinson’s disease 
and vascular dementia. In addition, patients with INPH 
may have comorbidities affecting cognition such as AD 
and cerebrovascular disease.27 28 Ventriculomegaly, the 
radiological hallmark of INPH, was present in about 
18% of non- INPH study participants and was associated 
with cerebral atrophy. This makes it difficult to deter-
mine if the ventricular enlargement in the elderly results 
from hydrocephalus or cerebral atrophy. An Evans ratio 
threshold for ventriculomegaly relevant to the diagnosis 
of INPH has not been validated previously.
A CDT that creates an individual Evans ratio threshold 
for each patient, based on their MWPH of lateral 
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Table 6 Change in subjective CIBIC plus scores over the 12 months following initial assessment in shunted and non- shunted 
participants
Non- shunted Shunted
Comparison: shunted versus 
non- shunted patients
N Mean SD N Mean SD Difference * (95% CI) P value
Global†
 Initial 5 −0.5 1.2 13 −1.4 0.9 0.00
 0–3 months‡ 1 −0.9 0.0 18 2.2 1.0 4.00 (1.3 to 6.7) 0.004
 3–9 months 21 −0.7 0.9 20 2.2 1.1 3.73 (2.67 to 4.79) <0.001
 9–16 months 13 −0.8 1.3 18 2.0 1.1 3.70 (2.38 to 5.03) <0.001
Dementia
 Initial 5 −0.5 1.3 13 −1.2 0.8 0.00
 0–3 months‡ 1 0.4 0.0 18 1.7 0.9 2.05 (−0.3 to 4.4) 0.09
 3–9 months 21 −0.9 0.8 20 1.8 1.2 3.42 (2.51 to 4.33) <0.001
 9–16 months 13 −0.7 1.4 18 2.0 1.2 3.41 (2.22 to 4.59) <0.001
Balance/gait
 Initial 5 −0.9 1.1 13 −0.9 0.8 0.00
 0–3 months‡ 1 −0.2 0.0 18 2.2 0.9 2.34 (−0.3 to 5.0) 0.09
 3–9 months 21 −1.1 1.0 20 2.3 1.0 3.43 (2.35 to 4.50) <0.001
 9–16 months 13 −1.3 1.2 18 1.8 1.4 3.07 (1.65 to 4.49) <0.001
Urinary
 Initial 5 −0.4 1.2 13 −0.5 0.7 0.00
 0–3 months 1 −0.4 0.0 18 1.7 1.6 2.16 (−1.2 to 5.5) 0.21
 3–9 months 21 −0.6 0.9 20 1.5 1.2 2.11 (0.90 to 3.32) 0.001
 9–16 months 13 −0.5 1.0 17 1.7 1.4 2.24 (0.87 to 3.62) 0.001
*Mean difference in scores between shunted and non- shunted participants, estimated using repeated measures mixed effects linear
regression adjusted for initial CIBIC- plus scores, with the time from initial assessment of the follow- up observations being treated as a
random variable.
†CIBIC- plus scores have a 7- point scale format: very much worsening, moderately worsening, minimally worsening, unchanged, minimally 
improved, moderately improved, very much improved.
CIBIC- plus, Clinician’s Interview Based Impression of Change Plus Caregiver Interview.
ventricles, might be a better predictor of the diagnosis of 
INPH. However, this is a preliminary finding and requires 
further refinement of the diagnostic definition using CT 
brain imaging. Moreover, intracranial measurements 
can vary depending on the location measured and axial 
slice angle. For CT scans and other imaging techniques 
conducted in specialist INPH assessment centres, the 
head position and slices angles need to be standardised. 
Additionally, day- to- day variations in patient positioning 
as well as variations in scanning protocol from institution 
to institution need to be taken into account.
 Outcome of shunt surgery
Studies on shunting for INPH revealed variable 
outcomes.2 18 29 30 This may be due to difference in patient 
selection criteria and postsurgical outcome measures. An 
earlier meta- analysis of 44 studies reported a low rate of 
improvement following shunting, with approximately 
59% experiencing short- term and 29% experiencing 
prolonged improvement.2 A recent review of 64 studies 
reported an average improvement of 71% following 
shunting,29 with improvement rates reaching 90% using 
of supplementary tests.30
It has been suggested that cognitive function is the 
least likely to improve following shunting leading to 
suggestion that INPH in the elderly should be consid-
ered a treatable gait disorder rather than treatable 
dementia.18 31 Furthermore, the presences of severe 
dementia, marked cerebral atrophy and extensive white 
matter ischaemia, have been used to exclude patients for 
shunt surgery.2 31 32 However, a recent systematic review of 
23 studies suggested an improvement of global cognitive 
function, verbal learning and memory and psychomotor 
speed following shunting.33 In our study, the majority 
of patients with INPH showed improvement of at least 
25% following shunting in either MMSE or balance/gait 
scores, and 56% improved by at least 50% in both in the 
first year. There was no association between the severity of 
initial symptoms and response to shunting, and the more 
pronounced symptoms were not associated with greater 
improvement.
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Figure 4 Association between proportional change in 
MMSE and Tinetti combined balance and gait scores in 
the shunted and non- shunted participants: mean change 
at all follow- up visits between 3 and 16 months (nominal 
6 month and 12 month clinic visits). MMSE, Mini- Mental State 
Examination.
 strengths and limitations of the study
The study of the incidence of INPH among patients with 
memory problems is epidemiologically robust, being 
prospective within a defined population and a well- 
established clinical service. The detailed clinical and 
radiological assessments and diagnoses are likely to have 
identified patients at early stages of the disease, while 
minimising ascertainment bias. Moreover, all presurgical 
and postsurgical assessments were performed indepen-
dent of the neurosurgeons, which reduced any selection 
or treatment- effect bias. The incidence of INPH among 
the Launceston memory clinic population has remained 
consistent over the last decade,10 maintained by the 
continuous awareness of the importance of diagnosing 
INPH.
There were limitations specific to this study. First, the 
lack of data on asymptomatic INPH or patients without 
memory problems. This is more likely to underestimate 
the true incidence of INPH. Second, there was the poten-
tial for bias due to missing data. The number of cases with 
missing data was relatively small (7.8%), and the method 
of substitution for that missing data was pessimistic, 
assuming random distribution of data when it was more 
likely that the missing data occurred with non- recording 
of negative findings. The more optimistic assumption 
predicted a specificity of 67.3% instead of 64.7% for the 
missing- at- random assumption. Third, the triage index test 
scores need to be externally validated in new populations 
to validate the scores with confidence. Fourth, the study 
was not a randomised, blinded or placebo- controlled clin-
ical trial due to ethical concerns that delaying accepted 
treatment in the control group allocation could lead 
to deterioration of the condition while waiting for trial 
follow- up.34 However, a recent open- labelled randomised 
trial of lumboperitoneal shunt surgery showed that shunt 
surgery improved functional status and symptoms for 
patients with INPH.26
 Conclusion and implications
This study has developed a simple assessment tool to 
predict the diagnosis of INPH which might be used by 
clinicians in non- specialised settings. The findings might 
improve timely and accurate recognition of the disorder, 
increase the awareness of clinicians to the higher inci-
dence of INPH among patients with memory prob-
lems and dementia, and that V- P shunting may help to 
improve cognitive, balance, gait and urinary functioning 
and overall quality of life. The diagnostic criteria and the 
incidence of INPH require further evaluation in different 
populations.
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